Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff

Newsfile February 20, 2020

Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020

GlobeNewswire February 18, 2020

Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara(TM) Mitral Valve System

Newsfile February 12, 2020

Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara(TM) Mitral Valve System

GlobeNewswire February 12, 2020

Neovasc Initiates Independent Inquiry into Trading of Its Shares

Newsfile February 11, 2020

Neovasc Initiates Independent Inquiry Into Trading of its Shares

GlobeNewswire February 11, 2020

Neovasc Provides Update on Nasdaq Compliance

Newsfile February 3, 2020

Neovasc Provides Update on Nasdaq Compliance

GlobeNewswire February 3, 2020

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer(TM) for Treatment of Refractory Angina

Newsfile January 31, 2020

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina

GlobeNewswire January 31, 2020

Neovasc Announces Executive Steering Committee for Transfemoral Trans-Septal Tiara Program

Newsfile January 28, 2020

Neovasc Announces Executive Steering Committee for Transfemoral Trans-septal Tiara Program

GlobeNewswire January 28, 2020

Neovasc Advances New Transfemoral Trans-Septal Tiara Design Concept After Further Successful Tests

Newsfile January 24, 2020

Neovasc Advances New Transfemoral Trans-septal Tiara Design Concept After Further Successful Tests

GlobeNewswire January 24, 2020

Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations in Germany

Newsfile January 22, 2020

Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations in Germany

GlobeNewswire January 22, 2020

Updates on Reducer and Tiara Programs Will be Presented at Advanced Cardiovascular Intervention 2020 Meeting

Newsfile January 21, 2020

Updates on Reducer and Tiara Programs Will be Presented at Advanced Cardiovascular Intervention 2020 Meeting

GlobeNewswire January 21, 2020

Neovasc Receives Administrative Acceptance Review Notification for Premarket Approval Application from FDA for the Neovasc Reducer(TM)

Newsfile January 15, 2020

Neovasc Receives Administrative Acceptance Review Notification for Premarket Approval Application from FDA for the Neovasc Reducer(TM)

GlobeNewswire January 15, 2020